A therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevents free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, (7) enhance mood.

Nutragenesis, LLC

Natreon, Inc.

Composition of ashwagandha and indian gooseberry

A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevent free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, and (7) enhance mood.

Method of preventing photo-aging with ashwagandha and Indian gooseberry

The invention provides a novel polyherbal composition useful for treating acute Hepatitis E virus infection including acute liver failure due to HEV infection, healthy Hepatitis B virus carriers who develop superadded hepatitis E virus infection, acute hepatitis B virus infection, and animal hepadna virus, therapeutic effects on hepatitis B virus infection and also used as a hepatoprotective agent, said composition comprising essentially extracts of plants Rheum emodi Wall., Phyllanthus amarus Linn., Eclipta alba Hassk., Andrographis paniculate Nees., and Picrorhiza kurroa Royle ex Benth., and optionally Fumaria officinalis, Tinospora cordifolia Miers., Terminalia chebula Retz., Cichorium intybus Linn., Tephrosea purpurea Linn. and Boerhaavia diffusa Linn.

Dabur Research Foundation

Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection

A method for the production of an extract of Phyllanthus wherein (a) Phyllanthuscomponents are extracted with an ethanol/water mixture of 5 85% m/m to which a heavy-metal chelator is added at a concentration of 0.001 3% m/m; (b) the primary extract obtained in step (a) is contacted and concentrated with (ba) Indian Sterculia gum at a final concentration of 0.5 5.0% mm relative to the sum of the extractive substances or (bb) one or more polymers and impendable and/or soluble substance(s); and (c) the concentrated extract obtained in step (b) is dried. The method according to the invention leads to particularly high yield of pharmaceutically effective plant ingredients and is thus of particular interest for therapeutic applications. In a preferred embodiment of the invention the method according to the invention includes a filtration step of the primary extract. It is further preferred that a lipoid is added during the extraction method. The Phyllanthus Phyllanthus amarus is preferred. Moreover, the invention relates to pharmaceutical compositions containing the extracts obtained by the method of the invention.

phyllanthus fischeri/antifúngic

Composition of ashwagandha and indian gooseberry

Method of preventing photo-aging with ashwagandha and Indian gooseberry

Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection

Method for the production of phyllanthus extracts

La base de dades d’herbes medicinals més completa avalada per la ciència